On the recordMarch 22, 2021
We want the orphan drug benefit, but we also don't want this kind of arbitrage where it then introduces a higher price than it should be for something else.
Source
congress.govEditor's note · Context
Cassidy emphasizes the need to balance orphan drug benefits with pricing issues.
Share & report
More from Bill Cassidy
Sep 17, 2025
Before 1991, as many as 20,000 babies —babies! — were infected with hepatitis B in the United States of America, and that changed when the hepatitis B vaccine was approved for newborns.
Sep 24, 2025
Workers in New York, and across the United States, should be able to assert their rights without confusion or undue difficulty.
Jul 8, 2025
We propose creating an additional investment fund — in parallel to the trust fund, not replacing it — that would be invested in stocks, bonds and other investments that generate a higher rate of return, helping keep the program from…
Other voices in this conversation
